UK Stocks-Factors to watch on April 27



April 27 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Wednesday, with futures FFIc1 up 0.26%.

* GSK: British drugmaker GSK GSK.L beat analyst expectations for its first-quarter profit and sales, ahead of the planned listing of its large consumer healthcare division in July, and stood by its forecasts for 2022.

* LSE: The London Stock Exchange Group said it was on track to meet all financial targets as it continued to integrate its $27 billion acquisition of data and analytics company Refinitiv.

* METRO BANK: British challenger lender Metro Bank MTRO.L said it was on track to deliver rising profits and achieve its strategic objectives after reporting first-quarter net loans and deposits at similar levels to the previous quarter.

* LLOYDS: Lloyds Banking Group LLOY.L reported better-than expected profits for the first three months of the year, as Britain's largest mortgage lender largely shrugged off the country's worsening cost of living crisis.

* TED BAKER: Ted Baker TED.L has received "a number" of proposals from potentially interested suitors, it said, after the British fashion retailer put itself up for sale earlier this month.

* PERSIMMON: Britain's second-largest homebuilder Persimmon PSN.L joined smaller rival Taylor Wimpey TW.L in dispelling inflation-led slowdown concerns as demand remained strong in an undersupplied housing market.

* WH SMITH: British retailer WH Smith SMWH.L reported a half-yearly profit following a recovery in sales and store footfall, helped by the easing of COVID-19 curbs and a recovery in global travel.

* BANK OF IRELAND: Bank of Ireland BIRG.I said that Chief Executive Francesca McDonagh would step down after five years in charge that saw the bank grow through acquisition, sharply cut staff numbers and almost fully return to private ownership.

* FTSE 100: London's FTSE 100 inched higher on Tuesday after a three-day sell-off, as resource and defensive stocks rose, while HSBC Holdings and Associated British Foods slid following earnings updates.

* For more on the factors affecting European stocks, please click on:

TODAY'S UK PAPERS

> Financial Times

> Other business headlines


Reporting by Amna Karimi in Bengaluru; Editing by Vinay Dwivedi

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.